The hyper mutated Omicron Covid variant, known to evade vaccine efficacy, cannot be deterred with two doses of Oxford-AstraZeneca or Pfizer-BioNTech Covid-19 shots, scientists at Oxford University have found.The yet to be peer-reviewed study, .
The coronavirus pandemic is disrupting universities and research institutes across the world. But the same institutions are also working very hard to find out how the disease can be stopped and its effects mitigated.
Follow this live blog for the latest updates on how the crisis is impacting research and innovation, and what governments, funders, companies, universities, associations and scientists are doing to stop or cope with the pandemic.
Two doses of Pfizer and AstraZeneca Covid-19 vaccines generate lower levels of antibodies against the Omicron variant of coronavirus, according to a study which suggests that those previously infected or vaccinated may be at an increased risk of infection. Researchers from the University of Oxford in the UK analysed the impact of the Omicron variant of concern on one of the
The coronavirus pandemic is disrupting universities and research institutes across the world. But the same institutions are also working very hard to find out how the disease can be stopped and its effects mitigated.
Follow this live blog for the latest updates on how the crisis is impacting research and innovation, and what governments, funders, companies, universities, associations and scientists are doing to stop or cope with the pandemic.